Insiders · PTHS

PTHS insider transactions

Pelthos Therapeutics Inc. (PTHS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PTHS

• 15d
  CFO, Treas & Secty Francis Knuettel Ii returned 13,947 shares to the company and sold $40,265 worth of shares (1,500 units at $26.84), decreasing direct ownership by 42% to 19,525 units (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 23d
  Director Friedberg Ezra M covered exercise/tax liability with 144 shares, decreasing direct ownership by 0.18% to 81,883 units (SEC Form 4) (withholding obligation)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 51d
  SEC Form 3 filed by new insider Gay John M.

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 65d
  SEC Form 4 filed by Malamut Richard

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 65d
  SEC Form 4 filed by Friedberg Ezra M

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 65d
  SEC Form 4 filed by Pauls Matthew

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 65d
  SEC Form 4 filed by Greenleaf Peter

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 70d
  Amendment: SEC Form 4 filed by Friedberg Ezra M

  4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 70d
  Amendment: SEC Form 4 filed by Davis Todd C

  4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 70d
  Amendment: SEC Form 4 filed by Malamut Richard

  4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 70d
  Amendment: SEC Form 4 filed by Plesha Scott M.

  4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 70d
  Amendment: SEC Form 4 filed by Greenleaf Peter

  4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 70d
  Amendment: SEC Form 4 filed by Pauls Matthew

  4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 70d
  Amendment: SEC Form 4 filed by Rangarao Sai

  4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 70d
  Amendment: SEC Form 4 filed by Baxter Richard B

  4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 70d
  Amendment: SEC Form 4 filed by Francis Knuettel Ii

  4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 163d
  Director Einhorn Andrew J. was granted 12,000 shares (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 163d
  SEC Form 3 filed by new insider Einhorn Andrew J.

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 180d
  Director Pauls Matthew converted options into 10,616 shares and gifted 9,542 shares (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 196d
  Director Friedberg Ezra M sold $280,280 worth of shares (10,000 units at $28.03) (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 212d
  SEC Form 4 filed by Director Ligand Pharmaceuticals Inc

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 322d
  SEC Form 4 filed by CEO and President Plesha Scott M.

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 322d
  SEC Form 3 filed by new insider Plesha Scott M.

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 324d
  SEC Form 4 filed by Chief Commercial Officer Rangarao Sai

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 324d
  SEC Form 3 filed by new insider Rangarao Sai

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)